Section Head, Vascular Medicine and Intervention
Massachusetts General Hospital
Boston, MA, United States
Dr. Rosenfield is an international leader, innovator, educator, and master clinician in vascular medicine and interventional cardiology. He served as National PI or Co-PI of numerous landmark clinical trials, including the NIH BEST-CLI trial, as well as Levant 2, ACT 1, Superb, Aspire, Artisan, HI-PEITHO and many others. He is past-president of SCAI, and has both led and served on numerous committees for SCAI, ACC, AHA. He founded the NCDR CARE Registry and the CREST 2 Registry, wrote standards for carotid stent operators and facilities, and has contributed to many PAD and CVD guidelines documents. He is the inaugural recipient of the LIVE award (Leaders in Vascular Education), received the AHA Laennec Master Clinician Award, and is a Master of SCAI. He was also the founder of the PERT Consortium. Dr. Rosenfield is considered a master clinician and interventionalist, an academic, a trialist, and a key opinion leader in peripheral intervention and pulmonary embolism.
Disclosure(s): Abbott Vascular: Advisor/Consultant (Ongoing); Angiodynamics: Advisor/Consultant (Ongoing); Biosense Webster: Advisor/Consultant (Ongoing); Boston Scientific Corporation: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Imperative Care: Advisor/Consultant (Ongoing), Ownership Interest (Ongoing), Stocks/Bonds (Ongoing); Medtronic: Advisor/Consultant (Ongoing); Neptune Medical: Advisor/Consultant (Ongoing), Ownership Interest (Ongoing), Stocks/Bonds (Ongoing); Philips: Advisor/Consultant (Ongoing)
172 - Challenging Cases in CIED
Friday, October 13, 2023
1:45 PM – 3:00 PM US ET